Investor Overview

Investor Presentation
Financial News
Sep 9, 2020

TORONTO, Ontario and HOUSTON, Texas, September 9, 2020 - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (Nasdaq: MDNA) (TSX: MDNA), a clinical stage immunooncology company, today...

Aug 20, 2020

Trading expected to begin August 24, 2020 TORONTO, Ontario and HOUSTON, Texas, August 20, 2020 - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (Nasdaq: MDNA) (TSX: MDNA), a clinical...

Stock Quote
Stock Chart
Upcoming Events
No events to display
Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
 
Email Alerts
* Required Fields